These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6117651)

  • 41. Tablet/Capsule Size Variation Among the Most Commonly Prescribed Medications for Children in the USA: Retrospective Review and Firsthand Pharmacy Audit.
    Jacobsen L; Riley K; Lee B; Bradford K; Jhaveri R
    Paediatr Drugs; 2016 Feb; 18(1):65-73. PubMed ID: 26801779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of stress on the gastric emptying of capsules.
    Kaus LC; Fell JT
    J Clin Hosp Pharm; 1984 Sep; 9(3):249-51. PubMed ID: 6490943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
    Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
    Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
    Gai MN; Pezoa R; Corbeaux J; Arancibia A
    Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of the conditions of absorption of determined drugs in various pharmaceutical oral forms].
    Cardini C; Stacchini A
    Boll Chim Farm; 1973 Feb; 112(2):104-9. PubMed ID: 4719965
    [No Abstract]   [Full Text] [Related]  

  • 47. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
    Armogida M; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.
    Christensen FN; Davis SS; Hardy JG; Taylor MJ; Whalley DR; Wilson CG
    J Pharm Pharmacol; 1985 Feb; 37(2):91-5. PubMed ID: 2858556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dosage form and resorption].
    Thoma K
    Internist (Berl); 1977 Dec; 18(12):617-27. PubMed ID: 340409
    [No Abstract]   [Full Text] [Related]  

  • 51. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
    Ellard GA
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S343-6; discussion S351-2. PubMed ID: 10593715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro kinetics of drug release from oral dosage forms, lyophilized and conventional rectal suppositories.
    Bhavnagri VP; Speiser P
    Pharm Acta Helv; 1976; 51(1):10-8. PubMed ID: 951423
    [No Abstract]   [Full Text] [Related]  

  • 55. Bioavailability of peroral dosage forms.
    Ritschel WA
    Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimation of bottle filling counts for conventional pharmaceutical tablets and capsules.
    Mullarney MP; Hutchins A; Taylor G
    Drug Dev Ind Pharm; 2015 Apr; 41(4):670-3. PubMed ID: 24592891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in vitro bioavailability of various drugs formulated as hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 Apr; 29(4):205-8. PubMed ID: 17668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct analysis of pharmaceutical tablet formulations using Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging.
    Earnshaw CJ; Carolan VA; Richards DS; Clench MR
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1665-72. PubMed ID: 20486264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions.
    Al-Numani D; Scarsi C; Ducharme MP
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):135-43. PubMed ID: 26754305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a method for study of the tendency of drug products to adhere to the esophagus.
    Marvola M; Vahervuo K; Sothmann A; Marttila E; Rajaniemi M
    J Pharm Sci; 1982 Sep; 71(9):975-7. PubMed ID: 7131280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.